Pages that link to "Q36544778"

The following pages link to Co-targeting of Bcl-2 and mTOR pathway triggers synergistic apoptosis in BH3 mimetics resistant acute lymphoblastic leukemia (Q36544778):

Displaying 15 items.

• Targeting PCDH20 gene by microRNA-122 confers 5-FU resistance in hepatic carcinoma (Q37215530) (← links)
• Effective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes (Q37392604) (← links)
• Control of B lymphocyte development and functions by the mTOR signaling pathways (Q38674507) (← links)
• Targeting mTOR for the treatment of B cell malignancies (Q38709825) (← links)
• Therapeutic targeting of IL-7Rα signaling pathways in ALL treatment (Q38856941) (← links)
• Inhibition of mTOR kinase as a therapeutic target for acute myeloid leukemia (Q39326047) (← links)
• The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cells (Q39819844) (← links)
• Enantiomerically pure β-dipeptide derivative induces anticancer activity against human hormone-refractory prostate cancer through both PI3K/Akt-dependent and -independent pathways (Q47103726) (← links)
• Targeting signaling and apoptotic pathways involved in chemotherapeutic drug-resistance of hematopoietic cells (Q47110143) (← links)
• Dual targeting of eIF4E by blocking MNK and mTOR pathways in leukemia (Q48057652) (← links)
• Predicting effective pro-apoptotic anti-leukaemic drug combinations using co-operative dynamic BH3 profiling (Q48316021) (← links)
• A Library of Phosphoproteomic and Chromatin Signatures for Characterizing Cellular Responses to Drug Perturbations. (Q55263249) (← links)
• Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An Update (Q56378380) (← links)
• Biological Aspects of mTOR in Leukemia (Q58780065) (← links)
• Targeting mTOR in Acute Lymphoblastic Leukemia (Q64118363) (← links)